Humana to Reduce Prior Authorizations, Increase Transparency for Medicare Advantage Plans by 2026
PorAinvest
jueves, 24 de julio de 2025, 2:37 pm ET1 min de lectura
HUM--
Humana's plan includes eliminating approximately one-third of prior authorizations for outpatient services by January 1, 2026. This includes removing authorization requirements for diagnostic services such as colonoscopies, transthoracic echocardiograms, and select CT scans and MRIs. The company aims to streamline the approval process, committing to provide a decision within one business day for at least 95% of all complete electronic prior authorization requests by the same date. Currently, Humana responds within one business day for over 85% of outpatient procedures.
In addition, Humana will launch a new "gold card" program in 2026, which will waive prior authorization requirements for certain items and services for providers who have a proven track record of meeting medical criteria and delivering high-quality care with consistent outcomes for Humana members.
The company has also committed to increased transparency, publicly reporting its prior authorization metrics in 2026. This data will include requests approved, denied, and approved after appeal, as well as the average time between submission and decision. This move aligns with ongoing federal transparency requirements.
Humana's efforts are part of a broader industry pledge to address prior authorization burdens, signed by dozens of insurers and supported by major lobbying organizations. The company's actions are aimed at reducing the administrative burden on physicians and improving patient care.
References:
[1] https://www.kiplinger.com/retirement/medicare/humana-to-reduce-prior-authorizations-for-medicare-advantage-plans-in-2026
[2] https://www.fiercehealthcare.com/payers/humana-makes-commitments-streamline-prior-authorization-process
[3] https://hitconsultant.net/2025/07/24/humana-accelerates-prior-authorization-reforms/
Humana, the second largest provider of Medicare Advantage plans, will reduce its use of prior authorizations and speed up the process for others by 2026. The company aims to streamline prior authorization processes for Medicare Advantage, Medicaid Managed Care, Health Insurance Marketplace, and commercial plans, covering nearly 80% of Americans. Humana will publicly report its prior authorization metrics in 2026, including data on requests approved, denied, and approved after appeal.
Humana, the second-largest provider of Medicare Advantage plans, has announced significant changes to its prior authorization processes, aiming to streamline them by 2026. These reforms are part of a broader industry effort to reduce administrative burdens on patients, caregivers, physicians, and healthcare organizations. The company has pledged to reduce prior authorization requirements and make the process faster and more seamless for all stakeholders.Humana's plan includes eliminating approximately one-third of prior authorizations for outpatient services by January 1, 2026. This includes removing authorization requirements for diagnostic services such as colonoscopies, transthoracic echocardiograms, and select CT scans and MRIs. The company aims to streamline the approval process, committing to provide a decision within one business day for at least 95% of all complete electronic prior authorization requests by the same date. Currently, Humana responds within one business day for over 85% of outpatient procedures.
In addition, Humana will launch a new "gold card" program in 2026, which will waive prior authorization requirements for certain items and services for providers who have a proven track record of meeting medical criteria and delivering high-quality care with consistent outcomes for Humana members.
The company has also committed to increased transparency, publicly reporting its prior authorization metrics in 2026. This data will include requests approved, denied, and approved after appeal, as well as the average time between submission and decision. This move aligns with ongoing federal transparency requirements.
Humana's efforts are part of a broader industry pledge to address prior authorization burdens, signed by dozens of insurers and supported by major lobbying organizations. The company's actions are aimed at reducing the administrative burden on physicians and improving patient care.
References:
[1] https://www.kiplinger.com/retirement/medicare/humana-to-reduce-prior-authorizations-for-medicare-advantage-plans-in-2026
[2] https://www.fiercehealthcare.com/payers/humana-makes-commitments-streamline-prior-authorization-process
[3] https://hitconsultant.net/2025/07/24/humana-accelerates-prior-authorization-reforms/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios